Ignite Creation Date:
2025-12-17 @ 9:12 PM
Ignite Modification Date:
2025-12-23 @ 11:09 PM
Study NCT ID:
NCT00769080
Status:
None
Last Update Posted:
2011-11-29 00:00:00
First Post:
2008-10-06 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Performance of Patient Support Program in Early Stage Breast Cancer
Sponsor:
None
Organization:
Study Overview
Official Title:
A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer
Status:
None
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARI NIS
Brief Summary:
The purpose of this study is to compare the 1-year adherence to upfront adjuvant AI for postmenopausal, early stage breast cancer in the two observational arms; Standard Treatment and Standard Treatment plus PSP arm after one year
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: